EP4054620
SEMAGLUTIDE IN THE TREATMENT OF ALZHEIMER'S DEMENTIA
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
5.11.2020EP published:
29.5.2024EP application number:
20803489.2
EPO information:
European Patent Register
Max expiry date:
4.11.2040
Title in English:
SEMAGLUTIDE IN THE TREATMENT OF ALZHEIMER'S DEMENTIALanguage of the patent:
English
Timeline
Today
5.11.2020EP application
29.5.2024EP Publication
Owner
Name:
Novo Nordisk A/SAddress:
Novo Allé, 2880 Bagsværd, DK
Inventor
Name:
FRIEDRICH, SarahAddress:
2880 Bagsværd, DK
Name:
HANSEN, Charlotte Christine ThimAddress:
2880 Bagsværd, DK
Name:
KNUDSEN, Lotte BjerreAddress:
2880 Bagsværd, DK
Name:
SECHER, AnnaAddress:
2880 Bagsværd, DK
Priority
Number:
19207501Date:
6.11.2019Country:
EP
Number:
20186623Date:
20.7.2020Country:
EP
Classification
Categories:
A61K 38/26, A61P 25/00